Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value ($000): $939,094 (99.2% shares, 0.8% debt)

Holdings (22)

INGN INOGEN INC 29.3%

Value ($000) $275,285 Shares 3,549,320 Est. Cost $17.78 Unrealized +289.7%

ANAB ANAPTYSBIO INC 9.0%

Value ($000) $84,180 Shares 3,033,504 Est. Cost $23.32 Unrealized 0.0%

— REATA PHARMACEUTICALS INC 8.1%

Value ($000) $76,280 Shares 3,367,763 Est. Cost $19.75 Unrealized —

IRTC IRHYTHM TECHNOLOGIES INC 8.1%

Value ($000) $76,119 Shares 2,024,448 Est. Cost $26.94 Unrealized +27.7%

CRVS CORVUS PHARMACEUTICALS INC 7.1%

Value ($000) $66,963 Shares 3,224,046 Est. Cost $14.33 Unrealized +9.3%

— RA PHARMACEUTICALS INC 4.6%

Value ($000) $43,252 Shares 2,031,562 Est. Cost $15.19 Unrealized —

— ACCELERON PHARMA INC 4.4%

Value ($000) $41,133 Shares 1,553,937 Est. Cost $27.65 Unrealized —

— FLEXION THERAPEUTICS INC 4.0%

Value ($000) $37,613 Shares 1,397,718 Est. Cost $16.32 Unrealized —

— MERUS N V 3.7%

Value ($000) $34,400 Shares 1,410,417 Est. Cost $7.99 Unrealized —

— SPECTRANETICS CORP 3.7%

Value ($000) $34,342 Shares 1,179,122 Est. Cost $18.19 Unrealized —

— OBSEVA SA 3.4%

Value ($000) $31,689 Shares 3,044,093 Est. Cost $10.41 Unrealized —

— NABRIVA THERAPEUTICS AG 3.0%

Value ($000) $27,919 Shares 2,326,544 Est. Cost $7.44 Unrealized —

— DERMIRA INC 2.7%

Value ($000) $25,522 Shares 748,240 Est. Cost $33.02 Unrealized —

KALV KALVISTA PHARMACEUTICALS INC 2.4%

Value ($000) $22,664 Shares 2,901,927 Est. Cost $7.37 Unrealized +1.9%

— APOLLO ENDOSURGERY INC 1.9%

Value ($000) $18,241 Shares 1,456,972 Est. Cost $12.16 Unrealized —

AKBA AKEBIA THERAPEUTICS INC 1.2%

Value ($000) $11,705 Shares 1,272,247 Est. Cost $9.76 Unrealized 0.0%

— INVUITY INC 1.1%

Value ($000) $10,482 Shares 1,318,448 Est. Cost $9.58 Unrealized —

— HTG MOLECULAR DIAGNOSTICS INC 0.9%

Value ($000) $8,859 Shares 1,280,185 Est. Cost $11.15 Unrealized —

— WRIGHT MED GROUP N V 0.8%

Value ($000) $7,072 Shares 4,622,032 Est. Cost $1.25 Unrealized —

CRSP CRISPR THERAPEUTICS AG 0.5%

Value ($000) $4,862 Shares 223,317 Est. Cost $18.69 Unrealized +5.1%

XENE XENON PHARMACEUTICALS INC 0.1%

Value ($000) $510 Shares 127,563 Est. Cost $14.68 Unrealized -46.5%

OPK OPKO HEALTH INC 0.0%

Value ($000) $2 Shares 259 Est. Cost $9.96 Unrealized -15.4%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
INGN	INOGEN INC	3,549,320	$275,285	29.3%	$17.78	+289.7%	COM	45780L104
ANAB	ANAPTYSBIO INC	3,033,504	$84,180	9.0%	$23.32	0.0%	COM	032724106
—	REATA PHARMACEUTICALS INC	3,367,763	$76,280	8.1%	$19.75	—	CL A	75615P103
IRTC	IRHYTHM TECHNOLOGIES INC	2,024,448	$76,119	8.1%	$26.94	+27.7%	COM	450056106
CRVS	CORVUS PHARMACEUTICALS INC	3,224,046	$66,963	7.1%	$14.33	+9.3%	COM	221015100
—	RA PHARMACEUTICALS INC	2,031,562	$43,252	4.6%	$15.19	—	COM	74933V108
—	ACCELERON PHARMA INC	1,553,937	$41,133	4.4%	$27.65	—	COM	00434H108
—	FLEXION THERAPEUTICS INC	1,397,718	$37,613	4.0%	$16.32	—	COM	33938J106
—	MERUS N V	1,410,417	$34,400	3.7%	$7.99	—	COM	N5749R100
—	SPECTRANETICS CORP	1,179,122	$34,342	3.7%	$18.19	—	COM	84760C107
—	OBSEVA SA	3,044,093	$31,689	3.4%	$10.41	—	COM	H5861P103
—	NABRIVA THERAPEUTICS AG	2,326,544	$27,919	3.0%	$7.44	—	COM	62957M104
—	DERMIRA INC	748,240	$25,522	2.7%	$33.02	—	COM	24983L104
KALV	KALVISTA PHARMACEUTICALS INC	2,901,927	$22,664	2.4%	$7.37	+1.9%	COM	483497103
—	APOLLO ENDOSURGERY INC	1,456,972	$18,241	1.9%	$12.16	—	COM	03767D108
AKBA	AKEBIA THERAPEUTICS INC	1,272,247	$11,705	1.2%	$9.76	0.0%	COM	00972D105
—	INVUITY INC	1,318,448	$10,482	1.1%	$9.58	—	COM	46187J205
—	HTG MOLECULAR DIAGNOSTICS INC	1,280,185	$8,859	0.9%	$11.15	—	COM	40434H104
—	WRIGHT MED GROUP N V	4,622,032	$7,072	0.8%	$1.25	—	RIGHT 03/01/2019	N96617126
CRSP	CRISPR THERAPEUTICS AG	223,317	$4,862	0.5%	$18.69	+5.1%	NAMEN AKT	H17182108
XENE	XENON PHARMACEUTICALS INC	127,563	$510	0.1%	$14.68	-46.5%	COM	98420N105
OPK	OPKO HEALTH INC	259	$2	0.0%	$9.96	-15.4%	COM	68375N103